Aviremic organ transplant dengue virus transmission – A case report

Jean Xiang Ying Sim, Esther S. Gan, Hwee Cheng Tan, Milly M. Choy, Hei Man Wong, Ban Hock Tan, Terence Kee, Quan Yao Ho, Sobhana Thangaraju, Raymond Tzer Pin Lin,

American Journal of Transplantation · 2021 · 19 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

Dengue virus (DENV), a mosquito-borne pathogen, causes systemic infections. There are no clear guidelines regarding the screening of donor blood is used in endemic countries to prevent blood transfusion or transplant-associated dengue. DENV has been shown to be detected in urine samples even when DENV viremia is undetectable. We describe an incident of transplant-associated dengue where the donor tested negative for DENV viremia but positive for DENV viuria resulting in the transmission of DENV to our two kidney recipients. Both recipients resolved DENV infection uneventfully, with no adverse impact on the renal graft. Our findings raise the consideration for revised screening recommendations in endemic countries to include DENV RT-PCR in the urine. Dengue virus (DENV), a mosquito-borne pathogen, causes systemic infections. There are no clear guidelines regarding the screening of donor blood is used in endemic countries to prevent blood transfusion or transplant-associated dengue. DENV has been shown to be detected in urine samples even when DENV viremia is undetectable. We describe an incident of transplant-associated dengue where the donor tested negative for DENV viremia but positive for DENV viuria resulting in the transmission of DENV to our two kidney recipients. Both recipients resolved DENV infection uneventfully, with no adverse impact on the renal graft. Our findings raise the consideration for revised screening recommendations in endemic countries to include DENV RT-PCR in the urine. Dengue is the most prevalent mosquito-borne viral infection in the world. This acute disease is caused by systemic infection with the Aedes mosquito-borne dengue virus (DENV).1World Health Organization, Research UUWBWSPF, Diseases TITHandbook for clinical management of dengue. World Health Organization, 2012Google Scholar An estimated 390 million people are infected with DENV each year. Only an estimated 25% of these are diagnosed as dengue; the majority of infections are asymptomatic or produce only undifferentiated acute febrile illness. Moreover, the clinical presentation of dengue may also be modified by age and other health status.2Chen LH Wilson ME. Update on non-vector transmission of dengue: relevant studies with Zika and other flaviviruses.Trop Dis Travel Med Vaccines. 2016; 2: 15Crossref Scopus (24) Google Scholar Such undetected infections can serve as nidi for further DENV transmission, including through non-mosquito–borne routes.3Cedano JA Mora BL Parra-Lara LG Manzano-Nuñez R Rosso F. A scoping review of transmission of dengue virus from donors to recipients after solid organ transplantation.Trans R Soc Trop Med Hyg. 2019; 113: 431-436Crossref Scopus (8) Google Scholar As DENV can be found in the liver, spleen, and lymph nodes of dengue patients at postmortem, DENV transmission through blood product transfusion and organ transplant from undiagnosed DENV infected donors has been reported.2Chen LH Wilson ME. Update on non-vector transmission of dengue: relevant studies with Zika and other flaviviruses.Trop Dis Travel Med Vaccines. 2016; 2: 15Crossref Scopus (24) Google Scholar To prevent such transfusion and transplant-associated infection in Singapore, blood from blood and organ donors has been, since November 2016, routinely screened for DENV by RT-PCR. This practice is based on the assumption that any active infection will result in the donors being viremic; recovered organs and urine are thus not routinely tested for DENV. Here, we report two deceased donor kidney transplants from a donor who was screened negative for DENV in the blood by RT-PCR but whose kidneys remained infected with DENV which resulted in two cases of donor-derived dengue infection. We describe these two patients and suggest that the inclusion of donor urine screening might be a safer strategy in the peri-transplant screening to prevent transplant-associated DENV infection. The deceased donor was a 26-year-old woman had undergone a gamma knife surgery for an intracranial arteriovenous malformation (AVM) 5 years before, was admitted electively to Hospital A on September 16, 2019 for a planned caesarean section. As she reported having fever the day before hospitalization, a series of investigations were performed, including a negative blood dengue NS1 antigen. There was no thrombocytopenia during that admission. She underwent an uneventful caesarean section on September 18, 2019 and was discharged 2 days later. She did not receive any blood products during that admission. On September 25, 2019, the donor was emergently admitted to hospital B due to an intracranial hemorrhage secondary to a ruptured AVM and demised on October 1, 2019. She was eligible for organ donation under the Human Organ Transplant Act. Blood from the deceased donor tested negative for DENV by RT-PCR at the time of organ procurement. The donor kidneys were of similar size and measured 10.5 cm in length each. These were transported from Hospital B to Hospital C through standardized national protocol and transplanted into two recipients (Recipients 1 and 2) on October 2, 2019. Both recipients developed DENV infection. Recipient 1, a 63-year-old man with IgA glomerulonephritis, had been undergoing renal replacement therapy 9 years prior to transplantation. Postoperatively, there was no delayed graft function. Induction regimen consisted of intravenous basiliximab and methylprednisolone, and was subsequently maintained on oral tacrolimus, mycophenolate mofetil, and prednisolone. Recipient 1 developed a fever 5 days after renal transplantation. He also developed new onset thrombocytopenia, which led to a test for DENV in his blood samples by RT-PCR. This turned out positive—serotyping and full genome sequencing confirmed the etiological agent to be DENV2. His fever lasted for 4 days, with a platelet nadir of 28x109/L (Figure 1A). Liver transaminases were raised and peaked at day 11 posttransplant (Figure 1B-C). Quantitative RT-PCR also revealed the peak RNAemia to be ~107genome copies/mL of serum (Figure 1D). Leftover serum from this patient taken just before transplant was tested for DENV by RT-PCR,4Santiago GA Vergne E Quiles Y et al.Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus.PLoS Negl Trop Dis. 2013; 7 (e2311.)Crossref Google Scholar and was negative. This patient, however, had prior DENV infection as his pretransplant blood was positive for anti-DENV IgG. Plaque reduction neutralization test (PRNT)5Ng KH Zhang SL Tan HC et al.Persistent dengue infection in an immunosuppressed patient reveals the roles of humoral and cellular immune responses in virus clearance.Cell Host Microbe. 2019; 26 (601-605.e3.)Abstract Full Text Full Text PDF Scopus (17) Google Scholar on blood collected at day 14 after fever onset detected antibodies that neutralized all four DENV serotypes. Serological analyses thus collectively suggest that Recipient 1 experienced a secondary DENV2 infection. Recipient 2 was a 39-year-old man with end-stage renal failure secondary to presumptive glomerulonephritis. His induction regimen consisted of intravenous antithymocyte globulin (ATG) and methylprednisolone, and was maintained on tacrolimus, mycophenolate, and prednisolone. Following the diagnosis of dengue in Recipient 1, we tested blood specimens from Recipient 2 for DENV by RT-PCR, which was positive also for DENV2. Peak RNAemia of Recipient 2 was ~105genome copies/mL of serum (Figure 1D), approximately 2 logs lower than Recipient 1. DENV2 was also isolated from the sera from both recipients. However, Recipient 2 was asymptomatic and had normal platelet counts. While alanine transaminase was mildly elevated, aspartate transaminase was within normal limits, unlike Recipient 1. Retrospective testing of pretransplant serum sample from Recipient 2 produced negative findings for DENV and anti-DENV IgM and IgG antibodies. Dengue IgM became positive at day 13 posttransplant. PRNT at day 40 after discovery of RT-PCR positivity for DENV revealed a monotypic DENV2 response, suggesting a primary DENV infection. As both Recipients 1 and 2 were infected with identical DENV serotype, we postulated that the route of virus transmission was through kidney transplantation. Hence, a postmortem investigation was carried out. As she had initially tested negative for DENV NS1 antigen and RNA in the blood, we performed RT-PCR for DENV RNA on leftover urine collected on the October 2, 2019. This was positive for DENV2; the RNA levels were unfortunately not sufficient for us to perform full viral genome sequencing. Subsequent epidemiological investigations also confirmed that the donor’s husband was diagnosed with dengue on September 11, 2019. DENV isolated from the donor’s husband was found to be of the same genotype based on the E1 gene sequence as both kidney recipients. Further investigations revealed that both recipients were not geographically linked and rigorous infection control reviews around the hospital did not reveal mosquito breeding sites for potential DENV transmission. Surveillance studies have also found that DENVs in Singapore are genetically diverse, with multiple strains of DENV being transmitted at any one time.6Lee KS Lo S Tan SS et al.Dengue virus surveillance in Singapore reveals high viral diversity through multiple introductions and in situ evolution.Infect Genet Evol. 2012; 12: 77-85Crossref Scopus (108) Google Scholar The likelihood that both recipients acquired their infection pretransplant and from the same source is thus unlikely. There was also no other dengue patient in the same ward at the time of the transplant. The donor’s liver recipient was found to be negative for transplant-associated DENV infection, further strengthening our postulate remnant DENV infection was not systemic but was rather specific to the kidneys. We continued to monitor the clinical condition of both the recipients, who recovered uneventfully. To further understand their clinical course, we sampled urine from these patients for viruria. Recipient 1 had RNAuria 1 log higher than Recipient 2 at 13 days posttransplant (Figure 1E). Moreover, we were able to isolate DENV2 from both patients over several days (Figure 1D and E). Likewise, consistent with a previous case of DENV infection in an immunosuppressed kidney transplant recipient, both viremia and viruria persisted for several weeks in both recipients (Figure 1D and E), likely due to the cocktail of immunosuppressants. RT-PCR is now widely used to test for DENV infection. While this test is useful for the diagnosis of acute dengue, its usefulness in ruling out asymptomatic infection should be questioned. In this case report, we present a circumstance where a negative blood DENV RT-PCR incorrectly ruled out DENV infection in the organ donor prior to procurement for transplantation. DENV RNA can be detected in urine samples at higher concentrations than blood samples a week after symptom onset,7Van den Bossche D Cnops L Van Esbroeck M. Recovery of dengue virus from urine samples by real-time RT-PCR.Eur J Clin Microbiol Infect Dis. 2015; 34: 1361-1367Crossref Scopus (20) Google Scholar and can persist well into convalescence when DENV viremia is no longer detectable. However, whether DENV RNAuria represents some level of persistent infection in the renal tract of immunocompetent convalescent dengue patients is unclear; a recent report described an immunosuppressed patient with RNAuria and viruria that lasted for 11 months following acute dengue. In this patient DENV NS1 antigen, which would only be expressed in actively infected cells, was found in this patient’s podocytes.5Ng KH Zhang SL Tan HC et al.Persistent dengue infection in an immunosuppressed patient reveals the roles of humoral and cellular immune responses in virus clearance.Cell Host Microbe. 2019; 26 (601-605.e3.)Abstract Full Text Full Text PDF Scopus (17) Google Scholar Such an infection could thus have happened in our donor, who was infected while pregnant. On one hand, she could have mounted an adaptive immune response to DENV infection, as suggested by the negative DENV RT-PCR finding in her blood sample, but the immune response may have been suboptimal to clear the infection. On the other hand, the possibility that dengue RNAuria represents persistent infection even in immunocompetent patients will have major implications for peri-transplant management. Both recipients resolved DENV infection uneventfully, despite a secondary DENV2 infection in Recipient 1, with no adverse impact on the renal graft. However, the duration of infection was prolonged, likely due to their immunosuppressed states.5Ng KH Zhang SL Tan HC et al.Persistent dengue infection in an immunosuppressed patient reveals the roles of humoral and cellular immune responses in virus clearance.Cell Host Microbe. 2019; 26 (601-605.e3.)Abstract Full Text Full Text PDF Scopus (17) Google Scholar This outcome was fortunate as transplant-associated dengue has shown poor outcome, with a mortality rate approaching 20%8Rosso F Pineda JC Sanz AM Cedano JA Caicedo LA. Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review.Braz J Infect Dis. 2018; 22: 63-69Crossref PubMed Scopus (22) Google Scholar as well as stormy posttransplant clinical progress9Tan Fl-S Loh DlSK Prabhakaran K. Dengue haemorrhagic fever after living donor renal transplantation.Nephrol Dial Transplant. 2005; 20: 447-448Crossref PubMed Scopus (0) Google Scholar and graft dysfunction.10Weerakkody RM Patrick JA Sheriff MHR. Dengue fever in renal transplant patients: a systematic review of literature.BMC Nephrol. 2017; 18: 15Crossref PubMed Scopus (27) Google Scholar However, there may be a selection bias of published reports as routine screening of DENV in donors is not universal. Notwithstanding the clinical outcomes in our renal recipients, our findings call for a review of dengue screening of organ donors, and consideration for the inclusion of urine testing for DENV RT-PCR in dengue endemic regions. Further studies are warranted to determine the feasibility of peri-transplant urine screening of donors for enhanced detection of dengue infection. The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

References

6